The Faculty and Student Scholarship section is provided as a service to the WSU College of Pharmacy and Pharmaceutical Sciences community for sharing publications, presentations, and other highly transactional types of information. Accuracy of the information presented is the responsibility of those who submitted it. Submissions are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity. Submission for Pharmaceutical Sciences faculty and PhD students can be directed to Kami Ryplewski and submissions for Pharmacotherapy faculty and Doctor of Pharmacy students to Leslie Plum.
FACULTY SCHOLARSHIP
Publications
Pharmaceutical Sciences associate professor Zhenjia Wang and postdoctoral fellow Yujie Su, published” Neutrophil-mediated delivery of nanocrystal drugs via photoinduced inflammation enhances cancer therapy” ACSNano, 2023, 17, 15542-15555. https://pubs.acs.org/doi/full/10.1021/acsnano.3c02013
Neumiller JJ and one Co-author. First-line therapy in T2D: has metformin been ‘dethroned’? Medscape Diabetes & Endocrinology. August 15, 2023. Available at: https://www.medscape.com/viewarticle/995230?src=
Kessel BA, Baker DE. Drug Evaluation – Rezafungin (Rezzayo). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2023.
Baker DE. Drug Evaluation –Omidubicel-onlv (Omisirge). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2023.
Baker DE. Drug Evaluation – Tofersen (Qalsody). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2023.
Ashok R, Baker DE. Drug Evaluation – Retifanlimab (Zynyz). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2023.
Selvaraju K, Baker DE. Drug Evaluation – Efanesoctocog alfa (Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl) (Altuviiio). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2023.
Baker DE. Drug Utilization Evaluation – Rezafungin (Rezzayo). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. July 2023.
Baker DE. Drug Evaluation – Perfluorohexyloctane Ophthalmic Solution (Miebo). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2023.
Zahller CT, Kessel BA, Baker DE. Drug Evaluation – Omaveloxolone (Skyclarys). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2023.
Mealey S, Kessel BA, Baker DE. Drug Evaluation – Trofinetide (Daybue). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2023.
Levien TL, Baker DE. Drug Evaluation – Leniolisib (Joenja). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2023.
Levien TL, Baker DE. Drug Evaluation – Fezolinetant (Veozah): Updated Evaluation. In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2023.
Baker DE. Drug Utilization Evaluation – Fezolinetant (Veozah). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. August 2023.
Kessel BA, Baker DE. Drug Evaluation – Beremagene geperpavec-svdt (Vyjuvek). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. September 2023.
Aslund-Nelson K, Kessel BA, Baker DE. Drug Evaluation – Fecal microbiota spores, live-brpk (Vowst). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. September 2023.
Kessel BA, Baker DE. Drug Evaluation – Sulbactam/durlobactam (Xacduro). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. September 2023.
Frenzel VCD, Kessel BA, Baker DE. Drug Evaluation – Mirikizumab: Preliminary Evaluation. In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. September 2023.
Baker DE. Drug Evaluation –Ritlecitinib (Litfulo). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. September 2023.
Baker DE. Drug Utilization Evaluation – Sulbactam/durlobactam (Xacduro). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. September 2023.
Kessel BA, Baker DE. Drug Evaluation – Sotagliflozin (Inpefa). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. October 2023.
Baker DE. Drug Evaluation – Epcoritamab-bysp (Epkinly). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. October 2023.
Baker DE. Drug Evaluation – Glofitamab-gxbm (Columvi). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. October 2023.
Levien TL, Baker DE. Drug Evaluation – Nirsevimab-alip (Beyfortus). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. October 2023.
Levien TL, Baker DE. Drug Evaluation – Respiratory Syncytial Virus Vaccines (Abrysvo & Arexvy). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. October 2023.
Baker DE. Drug Utilization Evaluation – Nirsevimab-alip (Beyfortus). In: Generali J, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Clinical Drug Information, LLC. October 2023.
Presentations
USTUR associate in research Stacey McComish presented a poster titled, “Death certificates vs. autopsy reports: misclassification of causes of death among USTUR Registrants”, at the 17th International Congress for Radiation Research in Montréal, Canada on August 30, 2023. USTUR associate in research Xirui Liu, USTUR adjunct faculty Florencio Martinez, and USTUR Director and Professor Sergey Tolmachev were faculty co-authors.
Xirui Liu presented a poster titled, “Impact of death certificate misclassifications on radiation cancer risk estimates”, at the 17th International Congress for Radiation Research in Montréal, Canada on August 30, 2023. Stacey McComish and Sergey Tolmachev were faculty co-authors.
USTUR associate professor Maia Avtandilashvili, Stacey McComish, and Sergey Tolmachev were co-authors on a presentation, “Modeling of a unique USTUR dataset: female nuclear worker treated with chelation therapy after plutonium inhalation”, at the 17th International Congress for Radiation Research in Montréal, Canada on August 27, 2023.
Maia Avtandilashvili and Sergei Tolmachev were co-authors on the presentation, “Long-term retention of plutonium in the respiratory tract compartments: chemical binding, scar-tissue retention, or systemic uptake?” at the 68th Annual Meeting of the Health Physics Society (HPS Annual Meeting) in National Harbor, MD on July 25, 2023.
USTUR research assistant professor Martin Šefl presented, “Plutonium in Rocky Flats Workers: Using Post-mortem Tissue Analyses to Evaluate Organ Content and Dose Estimates Based on Monitoring Data”, at the HPS Annual Meeting on July 25, 2023. Maia Avtandilashvili and Sergey Tolmachev were faculty co-authors.
Sergey Tolmachev presented, “Improving Uncertainty Estimates of Plutonium Activity Concentration in Human Skeleton from Individual Bone Sample Analyses”, at the HPS Annual Meeting on July 25, 2023. Maia Avtandilashvili, Martin Šefl, and USTUR associate professor George Tabatadze were faculty co-authors.
George Tabatadze presented, “Mapping ²²⁶Ra Micro-Distribution in Radium Dial Painter Skeleton”, at the HPS Annual Meeting on July 25, 2023. Sergey Tolmachev was a faculty co-author.
Sergey Tolmachev was a co-author on the presentation, “MPS Hanford Cohort Dosimetry: Internal Dose Reconstruction Approaches”, at the HPS Annual Meeting on July 26, 2023.
Sergey Tolmachev, Maia Avtandilashvili, and George Tabatadze were co-authors on the presentation, “Radium Dial Painter Dosimetry: Person-Centered Innovations”, at the HPS Annual Meeting on July 26, 2023.
Joshua Neumiller presented a national webinar for the Association of Diabetes Care and Education Specialists (ADCES) on September 6, 2023 titled: “Update on Diabetes Care and Education in People with Diabetes and Chronic Kidney Disease.”
Joshua J. Neumiller presented a national webinar for Pharmacy Times Continuing Education (PTCE) titled: “Tailoring recommendations for people living with type 2 diabetes and chronic kidney disease: The role of the pharmacist” on September 12, 2023.
Service
Josh Neumiller served as faculty for the ASHP Diabetes Management Certificate, published August 30, 2023. The program is available at: https://elearning.ashp.org/products/10824/diabetes-management-certificate
Grants & Awards
Pharmaceutical Sciences assistant professor Hui Zhang received $1,775,908 from the National Cancer Institute (NCI) for a research project titled, “Mechanism of double-negative T cells in antitumor immunity to breast cancer.”
STUDENT ACHIEVEMENT
Pharmaceutical Sciences and Molecular Medicine students
Successfully Passed Preliminary Exam:
Siavosh Naji-Talakar, August 28, 2023